Zoster Myelitis:Improvement with Antiviral Therapy in Two Cases
Neurol 47:929-931, deSilva,S.M.,et al, 1996
Cytomegalovirus Encephalitis
Ann Int Med 125:577-578, Arribas,J.R.,et al, 1996
The Role of Lab Investig in the Dx & Management of Pts with Suspected Herpes Simplex Encephalitis:A Consensus Rpt
JNNP 61:339-345, Clinque,P.,et al, 1996
Total Alopecia, Diabetes Mellitus, and Falls
Lancet 348:1420, Mueller-Schoop,J.W., 1996
Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996
Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996
Nonsystemic Vasculitic Mononeuropathy Multiplex, Cryoglobulinemia, and Hepatitis C
Muscle & Nerve 19:1596-1602996., David,W.S.,et al, 1996
Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996
Ganciclovir-Induced Psychosis
NEJM 335:1937, Hansen,B.A.,et al, 1996
Immunosuppression-Induced Leukoencephalopathy from Tacrolimus (FK506)
Ann Neurol 40:575-580, Small,S.L.,et al, 1996
Low-Dose Oral Methotrexate in Chronic Progressive Multiple Sclerosis:Analyses of Serial MRIs
Neurol 47:1153-1157, Goodkin,D.E.,et al, 1996
Linomide Reduces the Rate of Active Lesions in Relapsing-Remitting Multiple Sclerosis
Neurol 47:895-900, Anderson,O.,et al, 1996
Botulinum Toxin:A Deadly Poison Sheds its Negative Image
Ann Int Med 125:616-617, Simpson,L.L., 1996
Tissue-Type Plasminogen Activator Should Not be Used in Acute Ischemic Stroke
Arch Neurol 53:1306-1308, Riggs,J.E., 1996
Thrombolysis for Stroke
Arch Neurol 53:1305-1306, 13081996., Brott,T., 1996
TPA Within 3 Hours of Acute Ischaemic Stroke
Lancet 348:1600-1601, Dorman,P.&Sandercock,P., 1996
A Reversible Posterior Leukoencephalopathy Syndrome
NEJM 334:494-500, Hinchey,J.,et al, 1996
Acute Meningitis with a Negative Gram's Stain:Clinical and Management Outcomes in 171 Episodes
Am J Med 100:78-84, Elmore,J.G.,et al, 1996
Meningitis, Vasculitis, and Cerebritis Caused by CNS Histoplasmosis:Radiologic-Pathologic Correlation
AJR 166:194-196, Zalduondo,F.M.,et al, 1996
Transient Ara-C Leukoencephalopathy:MR Findings
J Comput Assist Tomogr 20:161-169, Patel,A.G.&Rao,R., 1996
Exacerbation of Myasthenia Gravis Associated with Cocaine Use
Neurol 46:271-272, Daras,M.,et al, 1996
Chronic Lymphocytic Leukemia and the Central Nervous System:A clinical and Pathological Study
Neurol 46:19-25, Cramer,S.C.,et al, 1996
Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996
Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Subjects Not Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:29-361996., , 1996
Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Patients Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:37-451996., , 1996
Neurotoxicity Related to the Use of Topical Tretinoin (Retin-A)
Ann Int Med 124:227-228, Bernstein,A.L.&Leventhal-Rochon,J.L., 1996
Peripheral Neuropathy Secondary to Docetaxel (Taxotere)
Neurol 46:108-111, 21996., New,P.Z.,et al, 1996
Peripheral Neurotoxicity Induced by Docetaxel
Neurol 46:104-108, 21996., Hilkens,P.H.E.,et al, 1996
Prognostic Value of the Hyperdense Middle Cerebral Artery Sign and Stroke Scale Score Before Ultraearly Thrombolytic Therapy
AJNR 17:79-85, Tomsick,T.,et al, 1996
Reversible Parkinsonism and Cognitive Impairment with Chronic Valproate Use
Neurol 47:626-635, Armon,C.,et al, 1996
Thrombolysis in Acute Stroke, Defining Risk to Benefit Ratio
BMJ 313:640-641, Bogousslavsky,J., 1996
Progressive Encephalomyelitis with Rigidity Responsive to Plasmapheresis and Immunosuppression
Ann Neurol 40:451-453, Fogan,L., 1996
Varicella Zoster Virus, A Cause of Waxing and Waning Vasculitis:The NEJM Case 5-1995 Revisited
Neurol 47:1441-1446, Gilden,D.H.,et al, 1996
Pravastatin Reduces Carotid Intima-Media Thickness Prog in an Asympt Hypercholesterolemic Pop, CAIUS Study
Am J Med 101:627-634, Mercuri,M.,et al, 1996
Good Clinical Outcome in a Pt with Large CT Scan Hypodensity Treated with Intra-Arterial Urokinase after Embolic Stroke
Neurol 47:1076-1078, Tarr,R.,et al, 1996
Streptokinase for Acute Ischemic Stroke with Relationship to Time of Administration
JAMA 276:961-966, 9951996., Donnan,G.A.,et al, 1996
Selegiline and Mortality in Parkinson's Disease
Ann Neurol 40:841-845, Olanow,C.W.,et al, 1996
Acute Demyelinating Polyneuropathy with Arsenic Ingestion
Muscle & Nerve 19:1611-1613996., Greenberg,S.A., 1996
Vinorelbine Neurotoxicity:Clinical and Neurophysiological Findings in 23 Patients
JNNP 61:409-411, Pace,A.,et al, 1996
Causes and Outcome of Seizures in Liver Transplant Recipients
Neurol 47:1523-1525, Wijdicks,E.F.M.,et al, 1996
Radiotherapy for Malignant Glioma
BMJ 313:1500-1501, Gregor,A.,et al, 1996
Routine Indomethacin Prophylaxis:Has the Time Come
Pediatrics 98:784-785, Bada,H.S., 1996
Clinical and Pathological Features in Hydrocarbon-Induced Parkinsonism
Ann Neurol 40:922-925, Pezzoli,G.,et al, 1996
Intermittent Cyclophosphamide & Prednisone Trtm of Polyneuropathy Assoc with Monocl Gamopathy of Undeter Sign
Neurol 47:1227-1233, Notermans,N.C.,et al, 1996
Movement Disorders Associated with the Serotonin Selective Reuptake Inhibitors
J Clin Psychiatry 57:449-454, Leo,R.J., 1996
Regional Subacute Cranial Neuropathies Following Internal Carotid Cisplatin Infusion
Neurol 47:1088-1090, Alderson,L.M.,et al, 1996
Intraarterial Thrombolysis in Vertebrobasilar Occlusion
AJNR 17:255-262, Becker,K.J.,et al, 1996
Concern About Safety of Carotid Angioplasty
Stroke 27:197-198, Beebe,H.G.,et al, 1996
Lubeluzole in Acute Ischemic Stroke:A Double-Blind Placebo-Controlled Phase II Trial
Stroke 27:76-81, Diener,H.C.,et al, 1996
The Residual Cognitive Effects of Heavy Marijiana Use in College Students
Pope. H. G. & Yurgelun-Todd, D. , JAMA 275:521-527, , 1996